...
首页> 外文期刊>Philosophical Transactions of the Royal Society of London, Series B. Biological Sciences >Effects of gene regulatory reprogramming on gene expression in human and mouse developing hearts
【24h】

Effects of gene regulatory reprogramming on gene expression in human and mouse developing hearts

机译:基因调控重编程对人和小鼠心脏发育中基因表达的影响

获取原文
获取原文并翻译 | 示例

摘要

Lineage-specific regulatory elements underlie adaptation of species and play a role in disease susceptibility. We compared functionally conserved and lineage-specific enhancers by cross-mapping 5042 human and 6564 mouse heart enhancers. Of these, 79 per cent are lineage-specific, lacking a functional orthologue. Heart enhancers tend to cluster and, commonly, there are multiple heart enhancers in a heart locus providing a regulatory stability to the locus. We observed little cross-clustering, however, between lineage-specific and functionally conserved heart enhancers suggesting regulatory function acquisition and development in loci previously lacking heart activity. We also identified 862 human-specific heart enhancers: 417 featuring sequence conservation with mouse (class II) and 445 with neither sequence nor function conservation (class III). Ninety-eight per cent of class III enhancers were deleted from the mouse genome, and we estimated a similar-sized enhancer gain in the human lineage. Human-specific enhancers display no detectable decrease in the negative selection pressure and are strongly associated with genes partaking in the heart regulatory programmes. The loss of a heart enhancer could be compensated by activity of a redundant heart enhancer; however, we observed redundancy in only 15 per cent of class II and III enhancer loci indicating a large-scale reprogramming of the heart regulatory programme in mammals.
机译:特定于谱系的调控元件是物种适应的基础,并在疾病易感性中起作用。通过交叉映射5042人和6564小鼠心脏增强剂,我们比较了功能保守和谱系特异性增强剂。其中79%是特定于谱系的,缺乏功能性直系同源物。心脏增强剂趋于聚集,并且通常在心脏基因座中存在多种心脏增强剂,从而为该基因座提供调节稳定性。我们观察到谱系特异性和功能保守的心脏增强剂之间几乎没有交叉聚类,表明以前缺乏心脏活动的基因座中的调节功能获得和发展。我们还确定了862种人类特异性心脏增强剂:417种具有小鼠序列保守性(II类)和445种既没有序列也没有功能保守(III类)。从小鼠基因组中删除了98%的III类增强子,我们估计了人类谱系中类似大小的增强子。人类特异性增强子在负选择压力方面没有显示出可检测的下降,并且与心脏调节程序中的基因表达密切相关。心脏增强剂的损失可以通过多余的心脏增强剂的活动来补偿。但是,我们仅在15%的II类和III类增强子基因座中观察到了冗余,表明哺乳动物中的心脏调节程序进行了大规模的重新编程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号